MRI

Originally published July 20.

The device could enable researchers to measure the total production of a target protein biomarker over periods of weeks, months, or possibly years, potentially providing data unavailable via single-time-point sampling techniques like blood draws, said one of the researchers.

The company made the disclosures as part of Agilent's fiscal second-quarter earnings report, which showed that total revenues grew 16 percent and that a net loss in the prior-year period swung to a profit in the current quarter.